STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

The creator of CRISPR babies is flirting again with infamy, this time through a mysterious alliance with an Internet-savvy ...

The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...

This study set out to answer that question using cutting-edge biotechnology. The team used CRISPR-Cas9 to engineer several ALS-causing mutations—including FUS P525L, FUS R495X, and TARDBP M337V ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

Prime Medicine, a biotech whose wild ambitions for a powerful ... Prime was initially formed in 2019, around a CRISPR-based technology from Broad Institute biochemist David Liu for making ...

Scientists identify a new CARF effector, Cat1, with a complex structure that depletes a key metabolite, halting viral replication by cutting off its energy supply. (Nanowerk News) Every living ...

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other ...

The CRISPR technique involves cutting DNA at a particular location to launch a natural repair process. Importantly, this biotech has proven that its technology works, scoring the first ever ...